{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:10Z","timestamp":1789628530169,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10620-026-10135-0","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:41:55Z","timestamp":1785166915000},"page":"5737-5744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Fistulizing Disease, Treatment Modalities, and Clinical Activity on Health-Related Quality of Life in Crohn\u2019s Disease"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-9256","authenticated-orcid":false,"given":"Haluk Tarik","family":"Kani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9817-2896","authenticated-orcid":false,"given":"Yasemin","family":"Kaldirim Armutcuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1539-501X","authenticated-orcid":false,"given":"Ilkay","family":"Ergenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4683-4858","authenticated-orcid":false,"given":"Begum","family":"Ozsarac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0412-9877","authenticated-orcid":false,"given":"Beyza Nur","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4910-2292","authenticated-orcid":false,"given":"Gamzenur","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5083-4182","authenticated-orcid":false,"given":"Bunyamin","family":"Oztemiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4997-3618","authenticated-orcid":false,"given":"Burak Can","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9695-9416","authenticated-orcid":false,"given":"Ozlen","family":"Atug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-9254","authenticated-orcid":false,"given":"Yesim","family":"Ozen Alahdab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"10135_CR1","unstructured":"McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC. 2025."},{"key":"10135_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4321\/s1130-01082004000600002","volume":"96","author":"V Cadahia","year":"2004","unstructured":"Cadahia V, Garc\u00eda-Carbonero A, Vivas S, Fuentes D, Ni\u00f1o P, Rebollo P et al. Infliximab improves quality of life in the short-term in patients with fistulizing Crohn\u2019s disease in clinical practice. Rev Esp Enferm Dig. 2004;96:369\u201374. https:\/\/doi.org\/10.4321\/s1130-01082004000600002. (PubMed PMID: 15230666).","journal-title":"Rev Esp Enferm Dig."},{"key":"10135_CR3","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/apt.16326","volume":"53","author":"D Tjandra","year":"2021","unstructured":"Tjandra D, Garg M, Behrenbruch C, McCormick J, Simkin P, Prentice R et al. Review article: investigation and management of internal fistulae in Crohn\u2019s disease. Aliment Pharmacol Ther. 2021;53:1064\u201379. https:\/\/doi.org\/10.1111\/apt.16326. (PubMed PMID: 33721351).","journal-title":"Aliment Pharmacol Ther."},{"key":"10135_CR4","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/ibd\/izab287","volume":"28","author":"L Tsai","year":"2022","unstructured":"Tsai L, McCurdy JD, Ma C, Jairath V, Singh S. Epidemiology and natural history of perianal Crohn\u2019s disease: a systematic review and meta-analysis of population-based cohorts. Inflamm Bowel Dis. 2022;28:1477\u201384. https:\/\/doi.org\/10.1093\/ibd\/izab287. (PubMed PMID: 34792604).","journal-title":"Inflamm Bowel Dis."},{"key":"10135_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","volume":"11","author":"G Bouguen","year":"2013","unstructured":"Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF et al. Long-term outcome of perianal fistulizing Crohn\u2019s disease treated with infliximab. Clin Gastroenterol Hepatol. 2013;11:975\u201381. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.042. (PubMed PMID: 23376316).","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10135_CR6","doi-asserted-by":"publisher","unstructured":"Spinelli A, Yanai H, Girardi P, Milicevic S, Carvello M, Maroli A, et al. 2023 The Impact of Crohn\u2019s Perianal Fistula on Quality of Life: Results of an International Patient Survey. Crohns Colitis 360. 5(3): https:\/\/doi.org\/10.1093\/crocol\/otad036. PubMed Central PMCID: PMCPMC10390083.","DOI":"10.1093\/crocol\/otad036"},{"key":"10135_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/apt.14599","volume":"47","author":"PF Vollebregt","year":"2018","unstructured":"Vollebregt PF, van Bodegraven AA, Markus-de Kwaadsteniet TML, van der Horst D, Felt-Bersma RJF. Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2018;47:1253\u201360. https:\/\/doi.org\/10.1111\/apt.14599. (PubMed PMID: 29520808).","journal-title":"Aliment Pharmacol Ther."},{"key":"10135_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/mib.0000000000000278","volume":"21","author":"M van der Have","year":"2015","unstructured":"van der Have M, Fidder HH, Leenders M, Kaptein AA, van der Valk ME, van Bodegraven AA et al. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions. Inflamm Bowel Dis. 2015;21:369\u2013377. https:\/\/doi.org\/10.1097\/mib.0000000000000278. (PubMed PMID: 25569738).","journal-title":"Inflamm Bowel Dis."},{"key":"10135_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000016938","volume":"17","author":"F Casellas","year":"1999","unstructured":"Casellas F, L\u00f3pez-Vivancos J, Vergara M, Malagelada J. Impact of inflammatory bowel disease on health-related quality of life. Dig Dis. 1999;17:208\u2013218. https:\/\/doi.org\/10.1159\/000016938. (PubMed PMID: 10754360).","journal-title":"Dig Dis."},{"key":"10135_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.crohns.2014.03.005","volume":"8","author":"S L\u00f6nnfors","year":"2014","unstructured":"L\u00f6nnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L. IBD and health-related quality of life \u2013 discovering the true impact. J Crohns Colitis. 2014;8:1281\u20136. https:\/\/doi.org\/10.1016\/j.crohns.2014.03.005. (PubMed PMID: 24662394).","journal-title":"J Crohns Colitis."},{"key":"10135_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.crohns.2007.06.005","volume":"1","author":"S Ghosh","year":"2007","unstructured":"Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn\u2019s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007;1:10\u201320. https:\/\/doi.org\/10.1016\/j.crohns.2007.06.005. (PubMed PMID: 21172179).","journal-title":"J Crohns Colitis."},{"key":"10135_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0016-5085(89)80080-0","volume":"96","author":"G Guyatt","year":"1989","unstructured":"Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804\u2013810 (PubMed PMID: 2644154).","journal-title":"Gastroenterology."},{"key":"10135_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","volume":"106","author":"EJ Irvine","year":"1994","unstructured":"Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn\u2019s Relapse Prevention Trial Study Group. Gastroenterology. 1994;106:287\u201396. https:\/\/doi.org\/10.1016\/0016-5085(94)90585-1. (PubMed PMID: 8299896).","journal-title":"Canadian Crohn\u2019s Relapse Prevention Trial Study Group. Gastroenterology."},{"key":"10135_CR14","first-page":"439","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u2013444 (PubMed PMID: 1248701).","journal-title":"National Cooperative Crohn\u2019s Disease Study. Gastroenterology."},{"key":"10135_CR15","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","volume":"125","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn\u2019s disease. Gastroenterology. 2003;125:1508\u20131530. https:\/\/doi.org\/10.1016\/j.gastro.2003.08.025. (PubMed PMID: 14598268).","journal-title":"Gastroenterology."},{"key":"10135_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","volume":"20","author":"EJ Irvine","year":"1995","unstructured":"Irvine EJ. Usual therapy improves perianal Crohn\u2019s disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol. 1995;20:27\u201332 (PubMed PMID: 7884173).","journal-title":"J Clin Gastroenterol."},{"key":"10135_CR17","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1136\/gutjnl-2019-320553","volume":"70","author":"SO Adegbola","year":"2021","unstructured":"Adegbola SO, Dibley L, Sahnan K, Wade T, Verjee A, Sawyer R et al. Development and initial psychometric validation of a patient-reported outcome measure for Crohn\u2019s perianal fistula: the Crohn\u2019s Anal Fistula Quality of Life (CAF-QoL) scale. Gut. 2021;70:1649\u201356. https:\/\/doi.org\/10.1136\/gutjnl-2019-320553.","journal-title":"Gut."},{"key":"10135_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/ecco-jcc\/jjy183","volume":"13","author":"E Vegni","year":"2019","unstructured":"Vegni E, Gilardi D, Bonovas S, Corr\u00f2 BE, Menichetti J, Leone D et al. Illness perception in inflammatory bowel disease patients is different between patients with active disease or in remission: a prospective cohort study. J Crohns Colitis. 2019;13:417\u2013423. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy183. (PubMed PMID: 30517669).","journal-title":"J Crohns Colitis."},{"key":"10135_CR19","doi-asserted-by":"publisher","unstructured":"Mu\u00f1oz Gonz\u00e1lez E, Durantez-Fern\u00e1ndez C, P\u00e9rez-P\u00e9rez L, de Dios-Duarte MJ. Influence of Coping and Self-Efficacy in Inflammatory Bowel Disease. Healthcare (Basel). 2023;11(8). https:\/\/doi.org\/10.3390\/healthcare11081113. PubMed PMID: 37107947; PubMed Central PMCID: PMCPMC10138294.","DOI":"10.3390\/healthcare11081113"},{"key":"10135_CR20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1177\/1359105312459094","volume":"18","author":"TL Rochelle","year":"2013","unstructured":"Rochelle TL, Fidler H. The importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and Crohn\u2019s disease. J Health Psychol. 2013;18:972\u201383. https:\/\/doi.org\/10.1177\/1359105312459094. (PubMed PMID: 23027780).","journal-title":"J Health Psychol."},{"key":"10135_CR21","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.4240\/wjgs.v15.i11.2537","volume":"15","author":"C Karki","year":"2023","unstructured":"Karki C, Athavale A, Abilash V, Hantsbarger G, Geransar P, Lee K et al. Multi-national observational study to assess quality of life and treatment preferences in patients with Crohn\u2019s perianal fistulas. World J Gastrointest Surg. 2023;15:2537\u201352. https:\/\/doi.org\/10.4240\/wjgs.v15.i11.2537. (PubMed PMID: 38111766).","journal-title":"World J Gastrointest Surg."},{"key":"10135_CR22","doi-asserted-by":"publisher","first-page":"2166374","DOI":"10.1080\/20016689.2023.2166374","volume":"11","author":"M Kato","year":"2023","unstructured":"Kato M, Yoneyama-Hirozane M, Iwasaki K, Matsubayashi M, Igarashi A. Health-related quality of life in health states corresponding to different stages of perianal fistula associated with Crohn\u2019s disease: a quantitative evaluation of patients and non-patients in Japan. J Mark Access Health Policy. 2023;11:2166374. https:\/\/doi.org\/10.1080\/20016689.2023.2166374. (PubMed PMID: 36684854).","journal-title":"J Mark Access Health Policy."},{"key":"10135_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/bf02237236","volume":"43","author":"TH Rockwood","year":"2000","unstructured":"Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG et al. Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9\u201316. https:\/\/doi.org\/10.1007\/bf02237236. (PubMed PMID: 10813117).","journal-title":"Dis Colon Rectum."},{"key":"10135_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.14309\/ajg.0000000000003465","volume":"120","author":"GR Lichtenstein","year":"2025","unstructured":"Lichtenstein GR, Loftus EV, Afzali A, Long MD, Barnes EL, Isaacs KL et al. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2025;120:1225\u201364. https:\/\/doi.org\/10.14309\/ajg.0000000000003465. (PubMed PMID: 40701562).","journal-title":"Am J Gastroenterol."},{"key":"10135_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ecco-jcc\/jjw160","volume":"11","author":"M Severs","year":"2017","unstructured":"Severs M, Mangen MJ, van der Valk ME, Fidder HH, Dijkstra G, van der Have M et al. Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease. J Crohns Colitis. 2017;11:342\u2013352. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw160. (PubMed PMID: 27647859).","journal-title":"J Crohns Colitis."},{"key":"10135_CR26","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/ajg.2010.140","volume":"105","author":"CN Bernstein","year":"2010","unstructured":"Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105:1994\u20132002. https:\/\/doi.org\/10.1038\/ajg.2010.140. (PubMed PMID: 20372115).","journal-title":"Am J Gastroenterol."},{"key":"10135_CR27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.4065\/81.11.1462","volume":"81","author":"SS Mahid","year":"2006","unstructured":"Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462\u20131471. https:\/\/doi.org\/10.4065\/81.11.1462. (PubMed PMID: 17120402).","journal-title":"Mayo Clin Proc."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10135-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10135-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10135-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:06:13Z","timestamp":1789625173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10135-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10135"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10135-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted by Marmara University, School of Medicine local ethical committee (Approval Date: 08.01.2021 Approval number: 09.2021.31).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patients.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}